Archive: 07/04/2014
Palbociclib shows promising results in patients with hormone receptor-positive metastatic breast cancer
The drug palbociclib, an inhibitor of cyclin-dependent kinases (CDK) 4 and 6, significantly improved progression-free survival when administered as a first-line treatment in patients with hormone receptor-positive, metastatic ...
Apr 7, 2014
Parental obesity and autism risk in the child
Several studies have looked at possible links between maternal obesity during pregnancy and the risk of developmental disorders in the child. However, paternal obesity could be a greater risk factor than maternal obesity, ...
Apr 7, 2014
Study proposes new treatment method for alcohol problems
(Medical Xpress)—A study published by the University at Buffalo Research Institute on Addictions (RIA) suggests a new approach to help certain people stop drinking.
Apr 7, 2014
Cancer metabolism drug AG-221 shows clinical activity in advanced blood cancers
AG-221, a novel inhibitor of isocitrate dehydrogenase (IDH) 2-mutant metabolic enzyme, was well tolerated and showed early promise in patients with advanced and refractory blood cancers harboring IDH2 mutations, according ...
Apr 7, 2014